Condensed Consolidated Financial Statement Details - Narrative (Details) $ in Thousands			3 Months Ended
	Mar. 04, 2024 USD ($)	Dec. 16, 2020 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)
Goodwill [Line Items]
Provision for inventory obsolescence			$ 1,006	$ 952
Impairment of other property, plant and equipment			0	13,200
Impairment of goodwill			$ 0	$ 76,501
2012 Purchase and Sale Agreement
Goodwill [Line Items]
Royalties liability discount rate			0.30
2020 Purchase and Sale Agreement
Goodwill [Line Items]
Royalties liability discount rate			0.19
Payment of transaction related to purchase and sale agreement		$ 210,000
Payment of transaction related to purchase and sale agreement if threshold is not achieved		$ 240,000
Amount exchanged to remove cap on royalties	$ 15,000
Proceeds from sale of royalty rights			$ 15,000
UCB Pharma Manufacturing Agreement
Goodwill [Line Items]
Net realizable value of assets			$ 2,400		$ 2,000